1. Home
  2. BLDP vs CMPX Comparison

BLDP vs CMPX Comparison

Compare BLDP & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ballard Power Systems Inc.

BLDP

Ballard Power Systems Inc.

HOLD

Current Price

$2.58

Market Cap

830.0M

Sector

Energy

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$6.18

Market Cap

926.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDP
CMPX
Founded
1979
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
830.0M
926.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
BLDP
CMPX
Price
$2.58
$6.18
Analyst Decision
Sell
Strong Buy
Analyst Count
7
11
Target Price
$2.24
$13.44
AVG Volume (30 Days)
3.3M
2.5M
Earning Date
03-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,252,000.00
N/A
Revenue This Year
$40.14
N/A
Revenue Next Year
$11.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$1.33
52 Week High
$4.10
$6.48

Technical Indicators

Market Signals
Indicator
BLDP
CMPX
Relative Strength Index (RSI) 42.35 60.13
Support Level $2.50 $5.69
Resistance Level $2.82 $6.40
Average True Range (ATR) 0.13 0.44
MACD -0.01 0.06
Stochastic Oscillator 24.68 80.90

Price Performance

Historical Comparison
BLDP
CMPX

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: